|Systematic (IUPAC) name|
|O3-[1-[di(phenyl)methyl]azetidin-3-yl] O5-propan-2-yl 2-amino-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|
|Legal status||℞ Prescription only|
|Mol. mass||582.64 g/mol|
|(what is this?)|
Azelnidipine (INN; marketed under the brand name Calblock) is a dihydropyridine calcium channel blocker. It is sold in Japan by Daiichi-Sankyo pharmaceuticals, Inc. Unlike nicardipine, it has a gradual onset and has a long-lasting hypotensive effect, with little increase in heart rate.
|This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.|